Mitchell Sabloff Selected Research

Mitchell Sabloff Research Topics

9	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 09/2010
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 05/2022 - 01/2016
5	Leukemia 10/2020 - 06/2012
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2021 - 07/2010
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 11/2014 - 10/2006
2	Graft vs Host Disease (Graft-Versus-Host Disease) 12/2017 - 07/2010
2	Infections 10/2016 - 06/2012
2	Thrombocytopenia (Thrombopenia) 10/2016 - 02/2015
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2014 - 10/2006
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 09/2014 - 03/2014
2	Aplastic Anemia (Anemia, Hypoplastic) 07/2011 - 12/2010
1	Sclerosing Cholangitis 01/2022
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022
1	Neoplasms (Cancer) 12/2019
1	Iron Overload 10/2017
1	Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic) 05/2017
1	Hematologic Neoplasms (Hematological Malignancy) 01/2017
1	Acute Promyelocytic Leukemia 01/2017
1	Hemorrhage 10/2016
1	Multiple Sclerosis 08/2016
1	Frailty 01/2016
1	Myasthenia Gravis 01/2016
1	Fatigue 01/2016
1	Lymphoma (Lymphomas) 11/2014
1	Stiff-Person Syndrome (Stiff Man Syndrome) 10/2014
1	Systemic Mastocytosis 10/2014
1	Thrombophlebitis 06/2012
1	Inflammation (Inflammations) 06/2012
1	beta-Thalassemia (Cooley's Anemia) 02/2011
1	Bronchiolitis Obliterans Syndrome 07/2010
1	Philadelphia Chromosome 07/2010

5	HLA Antigens (Human Leukocyte Antigens)IBA 09/2014 - 09/2010
2	Busulfan (Busulfex)FDA Link 11/2021 - 12/2013
1	Hypoglycemic Agents (Hypoglycemics)IBA 05/2022
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2022
1	Sirolimus (Rapamycin)FDA Link 01/2022
1	Melphalan (Alkeran)FDA LinkGeneric 11/2021
1	fludarabineIBA 11/2021
1	nelarabine (506U78)FDA Link 01/2021
1	daratumumabIBA 01/2021
1	plerixafor FDA Link 10/2020
1	Erythropoietin FDA Link 12/2017
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 12/2017
1	MicroRNAs (MicroRNA)IBA 12/2017
1	IronIBA 10/2017
1	Arsenic Trioxide (Trisenox)FDA Link 01/2017
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2017
1	Antifibrinolytic Agents (Antifibrinolytics)IBA 10/2016
1	Tranexamic Acid (AMCA)FDA Link 10/2016
1	fms-Like Tyrosine Kinase 3IBA 10/2016
1	AntibodiesIBA 08/2016
1	Biological ProductsIBA 04/2015
1	AnthracyclinesIBA 01/2015
1	Azacitidine (5 Azacytidine)FDA Link 10/2014
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2013
1	Rituximab (Mabthera)FDA Link 03/2013
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 06/2012
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2011

11	Transplantation 01/2022 - 07/2010
10	Therapeutics 10/2020 - 06/2012
10	Cell Transplantation 10/2020 - 03/2014
7	Hematopoietic Stem Cell Transplantation 01/2022 - 10/2006
7	Drug Therapy (Chemotherapy) 10/2020 - 03/2013
6	Stem Cell Transplantation 10/2016 - 10/2006
2	Bone Marrow Transplantation (Transplantation, Bone Marrow) 02/2011 - 12/2010
1	Liver Transplantation 01/2022
1	Salvage Therapy 01/2021
1	Chelation Therapy (Therapy, Chelation) 10/2017
1	Length of Stay 10/2016
1	Activities of Daily Living (ADL) 01/2016
1	Homologous Transplantation 02/2014
1	Catheters 06/2012
1	Induction Chemotherapy 06/2012
1	Vascular Access Devices (Arterial Line) 06/2012